International Assets Investment Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

International Assets Investment Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-164,557	Closed	-$3.3K	–	1706
2024 Q3	$3.3K	Buy	+164,557	New	+$6M	0.01%	710
2023 Q1	–	Sell	-5,425	Closed	-$202K	–	1342
2022 Q4	$202K	Buy	+5,425	New	+$163K	0.02%	622
2021 Q2	–	Sell	-182	Closed	-$9K	–	1629
2021 Q1	$9K	Hold	182	–	–	﹤0.01%	1606
2020 Q4	$9K	Buy	+182	New	+$8.66K	﹤0.01%	1472

Other funds holding SBIO

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

PWA

Phoenix Wealth Advisors Chapel Hill, North Carolina $297M AUM 17.87% 1-Year Est. Return

International Assets Investment Management's SBIO Position: Q4 2024 in Review

International Assets Investment Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2024, closing a stake of 164,557 shares — an estimated $3.3K sold.

International Assets Investment Management first reported a position in SBIO in Q4 2020 and held it in 4 quarters. The position peaked at $202K in Q4 2022. 35 funds tracked by Wall St. Rank hold SBIO as of Q4 2024.

International Assets Investment Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2024 after selling out during the quarter.
International Assets Investment Management sold 164,557 ALPS Medical Breakthroughs ETF shares in Q4 2024, an estimated $3.3K.
International Assets Investment Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2020 and held it in 4 quarters.
International Assets Investment Management's ALPS Medical Breakthroughs ETF position peaked at $202K in Q4 2022.
35 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.